Compare Stocks: TDOC, AMZN, CRSP, and ROKU

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMZN Amazon.com	$265.00 -0.9%	$247.35	$196.00 ▼ $287.20	$2.86T	1.45	49.68 million shs	23.16 million shs
CRSP CRISPR Therapeutics	$54.10 +0.2%	$52.43	$44.12 ▼ $78.48	$5.23B	1.74	1.78 million shs	589,960 shs
ROKU Roku	$154.08 +1.5%	$139.92	$78.53 ▼ $153.99	$22.72B	2.01	3.67 million shs	1.07 million shs
TDOC Teladoc Health	$6.94 +3.4%	$8.16	$4.40 ▼ $9.89	$1.26B	2.12	5.52 million shs	2.35 million shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMZN Amazon.com	-1.83%	-1.97%	+8.07%	+0.02%	+20.68%
CRSP CRISPR Therapeutics	-0.15%	+2.94%	+6.64%	+7.02%	-4.61%
ROKU Roku	+0.58%	+3.29%	+6.64%	+20.61%	+80.02%
TDOC Teladoc Health	-1.53%	-3.10%	-30.57%	+1.59%	-2.47%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMZN Amazon.com	$265.00 -0.9%	$247.35	$196.00 ▼ $287.20	$2.86T	1.45	49.68 million shs	23.16 million shs
CRSP CRISPR Therapeutics	$54.10 +0.2%	$52.43	$44.12 ▼ $78.48	$5.23B	1.74	1.78 million shs	589,960 shs
ROKU Roku	$154.08 +1.5%	$139.92	$78.53 ▼ $153.99	$22.72B	2.01	3.67 million shs	1.07 million shs
TDOC Teladoc Health	$6.94 +3.4%	$8.16	$4.40 ▼ $9.89	$1.26B	2.12	5.52 million shs	2.35 million shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMZN Amazon.com	-1.83%	-1.97%	+8.07%	+0.02%	+20.68%
CRSP CRISPR Therapeutics	-0.15%	+2.94%	+6.64%	+7.02%	-4.61%
ROKU Roku	+0.58%	+3.29%	+6.64%	+20.61%	+80.02%
TDOC Teladoc Health	-1.53%	-3.10%	-30.57%	+1.59%	-2.47%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMZN Amazon.com	2.98	Moderate Buy	$322.56	21.72% Upside
CRSP CRISPR Therapeutics	2.58	Moderate Buy	$68.06	25.79% Upside
ROKU Roku	2.37	Hold	$156.25	1.41% Upside
TDOC Teladoc Health	2.25	Hold	$7.54	8.63% Upside

Current Analyst Ratings Breakdown

Latest TDOC, AMZN, CRSP, and ROKU Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/11/2026	ROKU Roku	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
8/11/2026	ROKU Roku	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/10/2026	ROKU Roku	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$160.00
8/7/2026	ROKU Roku	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/7/2026	ROKU Roku	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$145.00 ➝ $160.00
8/7/2026	ROKU Roku	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$126.00 ➝ $172.00
8/6/2026	CRSP CRISPR Therapeutics	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$55.00
8/4/2026	CRSP CRISPR Therapeutics	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$82.00 ➝ $88.00
8/4/2026	AMZN Amazon.com	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/3/2026	AMZN Amazon.com	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy (B)
8/3/2026	AMZN Amazon.com	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$325.00

(Data available from 8/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMZN Amazon.com	$716.92B	3.99	$13.00 per share	20.38	$51.14 per share	5.18
CRSP CRISPR Therapeutics	$3.51M	1,490.32	N/A	N/A	$18.06 per share	3.00
ROKU Roku	$4.74B	4.80	$2.96 per share	52.01	$19.15 per share	8.05
TDOC Teladoc Health	$2.53B	0.50	$1.84 per share	3.78	$7.21 per share	0.96

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMZN Amazon.com	$77.67B	$12.43	21.32	25.05	1.81	17.44%	18.00%	8.97%	10/29/2026 (Estimated)
CRSP CRISPR Therapeutics	-$581.60M	-$4.76	N/A	N/A	N/A	-3,368.72%	-24.39%	-18.25%	N/A
ROKU Roku	$88.36M	$2.34	65.85	39.71	N/A	6.82%	13.73%	8.34%	10/29/2026 (Estimated)
TDOC Teladoc Health	-$200.32M	-$0.99	N/A	N/A	N/A	-7.13%	-12.15%	-5.83%	10/28/2026 (Estimated)

Latest TDOC, AMZN, CRSP, and ROKU Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2026	Q2 2026	ROKU Roku	$0.61	$1.08	+$0.47	$1.08	$1.30 billion	$1.35 billion
8/3/2026	Q2 2026	CRSP CRISPR Therapeutics	-$1.19	-$0.94	+$0.25	-$0.94	$7.45 million	$10.18 million
7/30/2026	Q2 2026	AMZN Amazon.com	$1.82	$5.75	+$3.93	$5.75	$197.03 billion	$200.61 billion
7/29/2026	Q2 2026	TDOC Teladoc Health	-$0.2498	-$0.21	+$0.0398	-$0.21	$615.44 million	$606.93 million
6/30/2026	Q2 2026	CRSP CRISPR Therapeutics	N/A	-$0.94	N/A	-$0.94	N/A	$10.18 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMZN Amazon.com	N/A	N/A	N/A	N/A	N/A
CRSP CRISPR Therapeutics	N/A	N/A	N/A	N/A	N/A
ROKU Roku	N/A	N/A	N/A	N/A	N/A
TDOC Teladoc Health	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMZN Amazon.com	0.23	1.03	0.87
CRSP CRISPR Therapeutics	0.34	17.85	17.85
ROKU Roku	N/A	2.87	2.77
TDOC Teladoc Health	N/A	0.83	0.81

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMZN Amazon.com	72.20%
CRSP CRISPR Therapeutics	69.20%
ROKU Roku	86.30%
TDOC Teladoc Health	76.82%

Insider Ownership

Company	Insider Ownership
AMZN Amazon.com	8.90%
CRSP CRISPR Therapeutics	5.20%
ROKU Roku	13.45%
TDOC Teladoc Health	0.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMZN Amazon.com	1,576,000	10.79 billion	9.83 billion	Optionable
CRSP CRISPR Therapeutics	460	96.69 million	91.67 million	Optionable
ROKU Roku	3,600	147.43 million	127.60 million	Optionable
TDOC Teladoc Health	5,600	181.68 million	180.41 million	Optionable

TDOC, AMZN, CRSP, and ROKU Headlines

Recent News About These Companies

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

August 13 at 10:00 AM | prnewswire.com

HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum

August 12 at 3:00 PM | finance.yahoo.com

Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity

August 12 at 3:00 PM | finance.yahoo.com

Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?

August 12 at 3:00 PM | finance.yahoo.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

August 11 at 6:16 PM | globenewswire.com

1 Internet Stock with Impressive Fundamentals and 2 We Question

August 9, 2026 | finance.yahoo.com

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

August 8, 2026 | fool.com

Teladoc Health (TDOC) Securities Investigation Notice - Levi & Korsinsky

August 7, 2026 | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

August 6, 2026 | prnewswire.com

Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced - Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

August 6, 2026 | tmcnet.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: Teladoc (TDOC) and Karyopharm Therapeutics (KPTI)

August 6, 2026 | theglobeandmail.com

Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

August 5, 2026 | businesswire.com

Teladoc Shares Plunged More Than 28% After Earnings. How to Play TDOC Here.

August 5, 2026 | barchart.com

Teladoc shares plunged more than 28% after earnings. How to play TDOC here.

August 5, 2026 | msn.com

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Teladoc Health (TDOC)

August 5, 2026 | globenewswire.com

TDOC Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Teladoc Health (TDOC)

August 5, 2026 | tmcnet.com

Dimensional Fund Advisors LP Decreases Stake in Teladoc Health, Inc. $TDOC

August 5, 2026 | marketbeat.com

Citigroup Issues Pessimistic Forecast for Teladoc Health (NYSE:TDOC) Stock Price

August 5, 2026 | americanbankingnews.com

TDOC Q2 Deep Dive: Cash Pay Decline and Insurance Shift Pressure Guidance

August 4, 2026 | finance.yahoo.com

Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors

August 3, 2026 | finance.yahoo.com

Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors

August 3, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

TDOC, AMZN, CRSP, and ROKU Company Descriptions

Amazon.com NASDAQ:AMZN

$265.00 -2.28 (-0.85%)

Closing price 03:59 PM Eastern

Extended Trading

$265.15 +0.15 (+0.06%)

As of 04:16 PM Eastern

Amazon.com, Inc. engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, Fire tablets, Fire TVs, Echo, Ring, Blink, and eero; and develops and produces media content. In addition, the company offers programs that enable sellers to sell their products in its stores; and programs that allow authors, independent publishers, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, it provides compute, storage, database, analytics, machine learning, and other services, as well as advertising services through programs, such as sponsored ads, display, and video advertising. Additionally, the company offers Amazon Prime, a membership program. The company's products offered through its stores include merchandise and content purchased for resale and products offered by third-party sellers. It serves consumers, sellers, developers, enterprises, content creators, advertisers, and employees. Amazon.com, Inc. was incorporated in 1994 and is headquartered in Seattle, Washington.

CRISPR Therapeutics NASDAQ:CRSP

$54.10 +0.11 (+0.21%)

Closing price 03:59 PM Eastern

Extended Trading

$53.92 -0.18 (-0.33%)

As of 04:15 PM Eastern

CRISPR Therapeutics is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.

Roku NASDAQ:ROKU

$154.08 +2.29 (+1.51%)

Closing price 03:59 PM Eastern

Extended Trading

$153.73 -0.35 (-0.23%)

As of 04:15 PM Eastern

Roku, Inc., together with its subsidiaries, operates a TV streaming platform in the United states and internationally. The company operates in two segments, Platform and Devices. Its streaming platform allows users to find and access TV shows, movies, news, sports, and others. The Platform segment offers digital advertising, including direct and programmatic video advertising, media and entertainment promotional spending, and related services; and streaming services distribution, such as subscription and transaction revenue shares, and sale of premium subscriptions and branded app buttons on remote controls. The Devices segment provides sale of streaming players, Roku-branded TVs, smart home products and services, audio products, and related accessories as well as licensing arrangements with service operators. Roku, Inc. was incorporated in 2002 and is headquartered in San Jose, California.

Teladoc Health NYSE:TDOC

$6.94 +0.23 (+3.38%)

Closing price 03:59 PM Eastern

Extended Trading

$6.96 +0.02 (+0.33%)

As of 04:15 PM Eastern

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TDOC, AMZN, CRSP, and ROKU Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TDOC, AMZN, CRSP, and ROKU Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TDOC, AMZN, CRSP, and ROKU Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

TDOC, AMZN, CRSP, and ROKU Company Descriptions

Amazon.com NASDAQ:AMZN

CRISPR Therapeutics NASDAQ:CRSP

Roku NASDAQ:ROKU

Teladoc Health NYSE:TDOC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TDOC, AMZN, CRSP, and ROKU Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TDOC, AMZN, CRSP, and ROKU Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TDOC, AMZN, CRSP, and ROKU Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

TDOC, AMZN, CRSP, and ROKU Company Descriptions

Amazon.com NASDAQ:AMZN

CRISPR Therapeutics NASDAQ:CRSP

Roku NASDAQ:ROKU

Teladoc Health NYSE:TDOC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools